CREX

Creative Realities, Inc.

48
Fundamentals43/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential28/ 100

CREX's outlook is improving, though it still trails on the overall score.

PLTR

Palantir Technologies Inc.

90
Fundamentals95/ 100
Valuation88/ 100
Upside potential84/ 100
Risk potential21/ 100

PLTR has the edge over CREX overall, supported by stronger fundamentals and stronger valuation.

CREX Fundamentals

MetricStatus
Strong
Weak
Weak
Stable

CREX's revenue is currently strong, and its balance sheet is stable, but its profitability and cash flow are weak.

PLTR Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.

CREX PE Valuation

CREX has no meaningful PE right now: it lost money over the past year.

PLTR PE Valuation

CHEAPFAIREXPENSIVE174x349x523x698x
CHEAPFAIREXPENSIVE174x349x523x698x
LevelPEPriceVs current
Forward75x$172—
Current120x$172—
Cheap165x$236+37%
Fair251x$359+109%
Expensive452x$646+277%

Historical ranges are pointers, not guarantees.

PLTR's PE is in its cheap range at 120x. If earnings grow as analysts expect, today's price would be 75x next year's earnings.

CREX Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
High

Analysts expect CREX's losses to shrink, with revenue growing.

PLTR Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.

CREX Risk to reward

ScenarioChangePrice
Upside+39%$2.98
Downside-27%$1.56

Calculated from the latest close: $2.15 on Nov 12.

CREX trails PLTR on modeled risk to reward, with less potential upside and more potential downside.

PLTR Risk to reward

ScenarioChangePrice
Upside+112%$364.26
Downside-21%$136.16

Calculated from the latest close: $171.58 on Nov 12.

PLTR has a better modeled risk to reward balance than CREX, with more potential upside and less potential downside.

CREX Earnings Per Share

Q4 2023: $-0.35Q1 2024: $-0.22Q2 2024: $-0.09Q3 2024: $0.14Q4 2024: $-0.34Q1 2025: $-0.01Q2 2025: $-0.12Q3 2025: $-0.88Q4 2025: $-0.81Q1 2026: $-1.87Q2 2026: $-2.11
Q4 2023: $-0.35Q1 2024: $-0.22Q2 2024: $-0.09Q3 2024: $0.14Q4 2024: $-0.34Q1 2025: $-0.01Q2 2025: $-0.12Q3 2025: $-0.88Q4 2025: $-0.81Q1 2026: $-1.87Q2 2026: $-2.11
QuarterTTM EPSYoY
Q2 2026-$2.11-$1.99
Q1 2026-$1.87-$1.86
Q4 2025-$0.81-$0.47
Q3 2025-$0.88-729%
Q2 2025-$0.12-$0.03
Q1 2025-$0.01+$0.21
Q4 2024-$0.34+$0.01
Q3 2022$0.15-55%

CREX is still losing money, but far less than before: $2.11 per share over the past year, against $5.16 at its worst in late 2020.

PLTR Earnings Per Share

Q4 2023: $0.09Q1 2024: $0.12Q2 2024: $0.17Q3 2024: $0.20Q4 2024: $0.19Q1 2025: $0.23Q2 2025: $0.30Q3 2025: $0.42Q4 2025: $0.63Q1 2026: $0.89Q2 2026: $1.17Q3 2026: $1.43Forward: $2.30
Q4 2023: $0.09Q1 2024: $0.12Q2 2024: $0.17Q3 2024: $0.20Q4 2024: $0.19Q1 2025: $0.23Q2 2025: $0.30Q3 2025: $0.42Q4 2025: $0.63Q1 2026: $0.89Q2 2026: $1.17Q3 2026: $1.43Forward: $2.30
QuarterTTM EPSYoY
Forward$2.30+61%
Q3 2026$1.43+240%
Q2 2026$1.17+290%
Q1 2026$0.89+287%
Q4 2025$0.63+232%
Q3 2025$0.42+110%
Q2 2025$0.30+76%
Q1 2025$0.23+92%
Q4 2024$0.19+111%

PLTR has the edge over CREX on earnings quality, reporting a profit while its opponent remains loss making.

CREX Quarterly Revenue

Q3 2023: $12MQ4 2023: $14MQ1 2024: $12MQ2 2024: $13MQ3 2024: $14MQ4 2024: $11MQ1 2025: $10MQ2 2025: $13MQ3 2025: $11MQ4 2025: $24MQ1 2026: $16MQ2 2026: $22M
Q3 2023: $12MQ4 2023: $14MQ1 2024: $12MQ2 2024: $13MQ3 2024: $14MQ4 2024: $11MQ1 2025: $10MQ2 2025: $13MQ3 2025: $11MQ4 2025: $24MQ1 2026: $16MQ2 2026: $22M
QuarterRevenueYoY
Q2 2026$21.5M+65%
Q1 2026$16.3M+68%
Q4 2025$23.9M+117%
Q3 2025$10.5M-27%
Q2 2025$13M-0.6%
Q1 2025$9.7M-21%
Q4 2024$11M-24%
Q3 2024$14.4M+25%

CREX's revenue is recovering but still below its 2022 peak: $22M last quarter, up 65% from the same quarter a year ago.

PLTR Quarterly Revenue

Q4 2023: $608MQ1 2024: $634MQ2 2024: $678MQ3 2024: $726MQ4 2024: $828MQ1 2025: $884MQ2 2025: $1BQ3 2025: $1.2BQ4 2025: $1.4BQ1 2026: $1.6BQ2 2026: $1.9BQ3 2026: $2.3B
Q4 2023: $608MQ1 2024: $634MQ2 2024: $678MQ3 2024: $726MQ4 2024: $828MQ1 2025: $884MQ2 2025: $1BQ3 2025: $1.2BQ4 2025: $1.4BQ1 2026: $1.6BQ2 2026: $1.9BQ3 2026: $2.3B
QuarterRevenueYoY
Q3 2026$2.3B+96%
Q2 2026$1.9B+93%
Q1 2026$1.6B+85%
Q4 2025$1.4B+70%
Q3 2025$1.2B+63%
Q2 2025$1B+48%
Q1 2025$883.9M+39%
Q4 2024$827.5M+36%

PLTR has the edge over CREX on sales, with more consistent year-over-year improvement.

CREX Free Cash Flow

Q3 2023: $2MQ4 2023: −$3MQ1 2024: $2MQ2 2024: $2MQ3 2024: $543,000Q4 2024: −$1MQ1 2025: −$2MQ2 2025: $672,000Q3 2025: −$2MQ4 2025: −$7MQ1 2026: −$2MQ2 2026: $457,000
Q3 2023: $2MQ4 2023: −$3MQ1 2024: $2MQ2 2024: $2MQ3 2024: $543,000Q4 2024: −$1MQ1 2025: −$2MQ2 2025: $672,000Q3 2025: −$2MQ4 2025: −$7MQ1 2026: −$2MQ2 2026: $457,000
QuarterFree cash flowYoY
Q2 2026$457K-32%
Q1 2026-$1.9M+$551K
Q4 2025-$7M-$5.6M
Q3 2025-$1.7M-415%
Q2 2025$672K-70%
Q1 2025-$2.5M-227%
Q4 2024-$1.4M+$1.8M
Q3 2024$543K-71%

CREX's free cash flow was −$10M over the past year, against −$3M the year before.

PLTR Free Cash Flow

Q4 2023: $296MQ1 2024: $127MQ2 2024: $141MQ3 2024: $416MQ4 2024: $457MQ1 2025: $304MQ2 2025: $532MQ3 2025: $501MQ4 2025: $764MQ1 2026: $892MQ2 2026: $1.2BQ3 2026: $1.2B
Q4 2023: $296MQ1 2024: $127MQ2 2024: $141MQ3 2024: $416MQ4 2024: $457MQ1 2025: $304MQ2 2025: $532MQ3 2025: $501MQ4 2025: $764MQ1 2026: $892MQ2 2026: $1.2BQ3 2026: $1.2B
QuarterFree cash flowYoY
Q3 2026$1.2B+139%
Q2 2026$1.2B+126%
Q1 2026$891.8M+193%
Q4 2025$764M+67%
Q3 2025$500.9M+20%
Q2 2025$531.6M+276%
Q1 2025$304.1M+140%
Q4 2024$457.2M+54%

PLTR has the edge over CREX on cash generation, producing positive trailing cash flow while its opponent burns cash.

CREX Total Shares

Q3 2023: 9MQ4 2023: 8MQ1 2024: 10MQ2 2024: 10MQ3 2024: 11MQ4 2024: 10MQ1 2025: 10MQ2 2025: 10MQ4 2025: 10MQ1 2026: 11MQ2 2026: 11M
Q3 2023: 9MQ4 2023: 8MQ1 2024: 10MQ2 2024: 10MQ3 2024: 11MQ4 2024: 10MQ1 2025: 10MQ2 2025: 10MQ4 2025: 10MQ1 2026: 11MQ2 2026: 11M
PeriodChange %Net change
Quarterly+0.2%+16K shares
1 year+1.2%+121K shares
3 years+44%+3.2M shares
5 years+211%+7.2M shares

CREX has 11M diluted shares, up 1.2% from a year ago.

PLTR Total Shares

Q4 2023: 2.3BQ1 2024: 2.4BQ2 2024: 2.4BQ3 2024: 2.5BQ4 2024: 2.5BQ1 2025: 2.6BQ2 2025: 2.6BQ3 2025: 2.6BQ4 2025: 2.6BQ1 2026: 2.6BQ2 2026: 2.6BQ3 2026: 2.6B
Q4 2023: 2.3BQ1 2024: 2.4BQ2 2024: 2.4BQ3 2024: 2.5BQ4 2024: 2.5BQ1 2025: 2.6BQ2 2025: 2.6BQ3 2025: 2.6BQ4 2025: 2.6BQ1 2026: 2.6BQ2 2026: 2.6BQ3 2026: 2.6B
PeriodChange %Net change
Quarterly+0.2%+5.2M shares
1 year+0.1%+2.9M shares
3 years+11%+248M shares
5 years+31%+610M shares
Available history+184%+1.7B shares

PLTR has the edge over CREX on shareholder dilution, with a more favorable share count trend.

CREX Net Leverage

Q3 2023: 4.8xQ4 2023: 2.3xQ1 2024: 2.1x
Q3 2023: 4.8xQ4 2023: 2.3xQ1 2024: 2.1x
QuarterNet LeverageStatus
Q1 20242.1xModerate
Q4 20232.3xModerate
Q3 20234.8xHigh
Q2 202313.2xHigh
Q1 202310.0xHigh
Q4 202245.2xHigh
Q4 20194.9xHigh

CREX's net debt is about 2.1 years of its operating earnings (EBITDA), down from 10 years a year ago.

PLTR Net Leverage

Q4 2023: -5.4xQ1 2024: -2.3xQ2 2024: -1.6xQ3 2024: -1.9xQ4 2024: -6.1xQ1 2025: -2.3xQ2 2025: -1.6xQ3 2025: -1.9xQ4 2025: -1.0xQ1 2026: -1.1xQ2 2026: -0.8xQ3 2026: -1.1x
Q4 2023: -5.4xQ1 2024: -2.3xQ2 2024: -1.6xQ3 2024: -1.9xQ4 2024: -6.1xQ1 2025: -2.3xQ2 2025: -1.6xQ3 2025: -1.9xQ4 2025: -1.0xQ1 2026: -1.1xQ2 2026: -0.8xQ3 2026: -1.1x
QuarterNet LeverageStatus
Q3 2026-1.1xNet Cash
Q2 2026-0.8xNet Cash
Q1 2026-1.1xNet Cash
Q4 2025-1.0xNet Cash
Q3 2025-1.9xNet Cash
Q2 2025-1.6xNet Cash
Q1 2025-2.3xNet Cash
Q4 2024-6.1xNet Cash

PLTR has more cash than debt.

CREX Weekly Momentum

MetricValueStatus
RSI33.0Neutral
Stochastic8.9Oversold

CREX's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).

PLTR Weekly Momentum

MetricValueStatus
RSI51.4Neutral
Stochastic47.4Neutral

PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).

CREX PE vs Technology Sector

MetricCREXSector medianRelative
PEN/A28x—

CREX has no meaningful PE right now: it lost money over the past year.

PLTR PE vs Technology Sector

MetricPLTRSector medianRelative
PE120x28x331% above
PE %13837 pts below

PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.

CREX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.254.4% below
20 week MA$2.7923% below
50 week MA$3.2033% below
100 week MA$2.8725% below
200 week MA$2.9828% below

CREX is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.

PLTR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$185.87.6% below
20 week MA$167.62.4% above
50 week MA$157.19.2% above
100 week MA$143.819% above
200 week MA$83.3106% above

PLTR has the edge over CREX on trend strength, trading above more of its moving averages.

CREX Yearly ROI

YearStart priceEnd priceROI
2020$4.20$3.90-7.1%
2021$3.90$4.38+12%
2022$4.38$1.71-61%
2023$1.71$2.36+38%
2024$2.36$2.69+14%
2025$2.69$2.66-1.1%
2026 YTD$2.66$2.15-19%

CREX has finished lower in three of the last six years. It's down 19% so far in 2026.

PLTR Yearly ROI

YearStart priceEnd priceROI
2020$9.20$27.8+202%
2021$27.8$18.9-32%
2022$18.9$6.29-67%
2023$6.29$17.2+173%
2024$17.2$79.1+361%
2025$79.1$188.7+139%
2026 YTD$188.7$171.6-9.1%

PLTR has the edge over CREX on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key